论文部分内容阅读
目的:分析索利那新与坦索罗辛联合治疗Ⅲ型前列腺炎的临床治疗效果。方法:选取我院2014年3月至2016年3月期间收治的Ⅲ型前列腺炎患者60例,将患者随机分配为研究组(共30例),对照组(共30例);其中对照组进行常规药物治疗,研究组患者进行索利那新与坦索罗辛联合治疗。观察比较两组患者的临床治疗满意度、临床治疗效果总有效率以及患者治疗前后的最大尿流率和平均尿流率。结果:研究组患者满意度、临床治疗效果总有效率以及患者治疗前后的最大尿流率以及平均尿流率明显优于对照组患者;两组患者结果差异比较有统计学意义(p<0.05)。结论:经研究发现,临床上应用索利那新与坦索罗辛联合治疗Ⅲ型前列腺炎能有效改善患者前列腺炎症状,有效提高Ⅲ型前列腺炎患者的治疗满意度与临床治疗效果总有效率,值得大力推广应用。
Objective: To analyze the clinical effects of solifenacin plus tamsulosin in the treatment of type Ⅲ prostatitis. Methods: Sixty patients with type Ⅲ prostatitis admitted from March 2014 to March 2016 in our hospital were randomly assigned to study group (30 cases in total) and control group (30 cases). Patients in control group Conventional drug therapy, study group patients with solifenac in combination with tamsulosin treatment. Two groups of patients were observed and compared the satisfaction of clinical treatment, the total effective rate of clinical treatment and patients before and after treatment, the maximum flow rate and the average flow rate of urine. Results: The study group satisfaction, the total effective rate of clinical treatment and patients before and after treatment, the maximum flow rate and the average flow rate was significantly better than the control group patients; two groups of patients with a statistically significant difference (p <0.05) . Conclusion: The study found that clinical application of solifenacin and tamsulosin combined treatment of prostatitis type Ⅲ can effectively improve the symptoms of prostatitis in patients with type Ⅲ prostatitis effectively improve the satisfaction of patients with treatment and the total effective rate of clinical treatment , It is worth to vigorously promote the application.